13D Filing: Glaxosmithkline Plc and Htg Molecular Diagnostics Inc (NASDAQ:HTGM)

Page 6 of 7 – SEC Filing

Cusip No. 40434H 10 4 13D/A1 Page 6
of 7
Dr. Moncef Slaoui

709 Swedeland Road

King of Prussia

PA, 19406

Executive Director and
Chairman, Global Vaccines
Moroccan, Belgian & US
Dr. Patrick Vallance 980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Executive Director and President, R&D British
Emma Walmsley 980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Executive Director and Chief Executive Officer Designate British
Corporate Executive Team
Sir Andrew Witty 980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Executive Director and Chief Executive Officer British
Roger Connor 980 Great West Road
Brentford
Middlesex, England
TW8 9GS
President, Global Manufacturing & Supply Irish
Luc Debruyne 980 Great West Road
Brentford
Middlesex, England
TW8 9GS
President, Global Vaccines Belgian
Simon Dingemans 980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Executive Director and Chief Financial Officer British
Nick Hirons 980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Senior Vice President, Global Ethics and Compliance British & US
Abbas Hussain 980 Great West Road
Brentford
Middlesex, England
TW8 9GS

President, Global Pharmaceuticals

British
Brian McNamara 184 Liberty Corner Road
Warren
NJ, 07059
Chief Executive Officer, GSK Consumer Healthcare US
David Redfern 980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Chief Strategy Officer British

Follow Htg Molecular Diagnostics Inc (NASDAQ:HTGM)